Qingdao Haier Biomedical Co.,Ltd (SHA:688139)
China
· Delayed Price · Currency is CNY 31.49
-0.16 (-0.51%)
Mar 9, 2026, 4:00 PM EDT
SHA:688139 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | - | 366.63 | 406.07 | 600.79 | 845.04 | Upgrade
|
| Depreciation & Amortization | - | 109.2 | 103.44 | 64.18 | 50.95 | Upgrade
|
| Other Amortization | - | 13.17 | 1.4 | 0.42 | 0.77 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.23 | 1.6 | 0.31 | - | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 1.86 | 5.31 | 0.45 | 1.85 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -29.26 | -85.09 | -67.71 | -483.48 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 16.03 | 5.82 | 1.12 | -3.86 | Upgrade
|
| Other Operating Activities | - | -5.71 | -7.05 | 54.28 | 41.39 | Upgrade
|
| Change in Accounts Receivable | - | -173.74 | 52.35 | -37.55 | 67.46 | Upgrade
|
| Change in Inventory | - | -68.72 | 38.34 | 76.78 | -99.12 | Upgrade
|
| Change in Accounts Payable | - | 76.51 | -252.2 | -72 | 124.42 | Upgrade
|
| Change in Other Net Operating Assets | - | - | - | 3.9 | 53.01 | Upgrade
|
| Operating Cash Flow | - | 291.67 | 249.26 | 632.43 | 591.8 | Upgrade
|
| Operating Cash Flow Growth | - | 17.01% | -60.59% | 6.87% | -15.05% | Upgrade
|
| Capital Expenditures | - | -126.7 | -177.18 | -294.24 | -204.69 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0.82 | 1.35 | 0.16 | 20.92 | Upgrade
|
| Cash Acquisitions | - | -160.41 | -214.99 | -115.35 | - | Upgrade
|
| Divestitures | - | - | - | - | 459.68 | Upgrade
|
| Investment in Securities | - | -521.03 | 573.19 | 66.02 | -1,827 | Upgrade
|
| Other Investing Activities | - | 16.11 | 70.38 | 92.24 | 49.21 | Upgrade
|
| Investing Cash Flow | - | -791.22 | 252.76 | -251.17 | -1,501 | Upgrade
|
| Short-Term Debt Issued | - | 189.52 | 6 | - | - | Upgrade
|
| Total Debt Issued | - | 189.52 | 6 | - | - | Upgrade
|
| Short-Term Debt Repaid | - | -198.59 | -22.5 | -5 | -25 | Upgrade
|
| Long-Term Debt Repaid | - | -4.36 | -5.87 | -1.87 | -1.71 | Upgrade
|
| Total Debt Repaid | - | -202.95 | -28.37 | -6.87 | -26.71 | Upgrade
|
| Net Debt Issued (Repaid) | - | -13.43 | -22.37 | -6.87 | -26.71 | Upgrade
|
| Issuance of Common Stock | - | - | - | 36.89 | - | Upgrade
|
| Repurchase of Common Stock | - | -40.46 | -1.67 | -98.07 | - | Upgrade
|
| Common Dividends Paid | - | -163.09 | -142.8 | -162.46 | -120.83 | Upgrade
|
| Other Financing Activities | - | -9.86 | -1.46 | 24.27 | 11.52 | Upgrade
|
| Financing Cash Flow | - | -226.83 | -168.3 | -206.23 | -136.01 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 4.43 | -8.24 | 8.9 | -1.54 | Upgrade
|
| Net Cash Flow | - | -721.94 | 325.48 | 183.92 | -1,047 | Upgrade
|
| Free Cash Flow | - | 164.96 | 72.08 | 338.18 | 387.11 | Upgrade
|
| Free Cash Flow Growth | - | 128.85% | -78.69% | -12.64% | -36.29% | Upgrade
|
| Free Cash Flow Margin | - | 7.22% | 3.16% | 11.81% | 18.21% | Upgrade
|
| Free Cash Flow Per Share | - | 0.52 | 0.23 | 1.06 | 1.22 | Upgrade
|
| Cash Income Tax Paid | - | 104.17 | 103.09 | 137.86 | 120.93 | Upgrade
|
| Levered Free Cash Flow | - | 4.09 | -221.96 | 225.74 | 168.55 | Upgrade
|
| Unlevered Free Cash Flow | - | 6.22 | -219.77 | 227.41 | 170.36 | Upgrade
|
| Change in Working Capital | - | -180.03 | -182.24 | -21.4 | 139.14 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.